Literature DB >> 2895213

Hodgkin's disease prognosis: a directly predictive equation.

P G Gobbi1, C Cavalli, M Federico, D Bertoloni, U A Di Prisco, A Rossi, V Silingardi, C Mauri, E Ascari.   

Abstract

586 patients with Hodgkin's disease diagnosed between 1970 and 1979 were staged and treated in the same way. Multivariate analysis was used to delineate the prognostic roles of several clinical features at diagnosis. A multiple regression analysis was applied to an exponential model for survival-time distribution, which proved to fit the data accurately. Several clinical characteristics were studied and those that could singly discriminate survival significantly were chosen as predictive variables for the multiple regression. These were: sex, age, stage, histological subtype, presence of constitutional symptoms, mediastinal mass, and erythrocyte sedimentation rate (ESR), and haemoglobin and serum albumin concentrations. ESR, stage, histological subtype, and age proved to be the best prognostic factors, while sex and albumin had minor value. The presence of symptoms, mediastinal bulk, and haemoglobin were not so important. A linear equation for the six variables was derived to calculate the estimated median survival time for any given patient. This equation was validated on an external group of 179 similar patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895213     DOI: 10.1016/s0140-6736(88)91477-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG).

Authors:  Ljubomir R Jakovic; Biljana S Mihaljevic; Maja D Perunicic Jovanovic; Andrija D Bogdanovic; Vesna M Cemerikic Martinovic; Tamara K Kravic; Vladimir Z Bumbasirevic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age.

Authors:  R F Jarrett; A Gallagher; D B Jones; F E Alexander; A S Krajewski; A Kelsey; J Adams; B Angus; S Gledhill; D H Wright
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

3.  Haemoglobin concentration and erythrocyte sedimentation rate in primary care patients.

Authors:  E J Kanfer; B A Nicol
Journal:  J R Soc Med       Date:  1997-01       Impact factor: 5.344

4.  Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.

Authors:  V Diehl; M Pfreundschuh; M Löffler; U Rühl; E Hiller; H Gerhartz; W Wilmanns; H Kirchner; W Schoppe; S Petsch
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

5.  Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.

Authors:  Theresa Hahn; Philip L McCarthy; Jeanette Carreras; Mei-Jie Zhang; Hillard M Lazarus; Ginna G Laport; Silvia Montoto; Parameswaran N Hari
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-03       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.